Substituted benzotriazole phenols

ABSTRACT

Benzotriazole phenols with substituents either ortho to the phenol hydroxyl group and/or para to the phenol hydroxyl group can be prepared from the unsubstituted benzotriazole phenol by coupling reactions. The ortho substituent group can be a simple alkoxy or amino group, or the ortho substituent group can be a linking group, linking the benzotriazole phenol to another benzotriazole phenol group.

FIELD OF THE DISCLOSURE

This disclosure relates to substituted phenol compounds, protectedsubstituted phenol compounds, and methods of preparing substitutedphenol compounds and protected substituted phenol compounds.

BACKGROUND

Phenols are class of chemical compounds having a hydroxyl group directlybonded to an aromatic hydrocarbon group. A wide variety of phenolics, ascompounds that contain a phenol group are called, are known. Somephenolics are produced by plants in nature and others have beensynthetically designed for a variety of chemical uses.

One class of phenolics are 2-(2-hydroxyphenyl)benzotriazoles orbenzotriazole phenols. Benzotriazole phenols are an important class ofUV absorbers, and in some cases, can absorb in the visible range aswell. These compounds are often used as additives in materials and caneven be incorporated into the polymeric structures via a polymerizablesubstituent on the benzotriazole phenol structure. A number ofbisbenzotriazolylphenol compounds are described in U.S. Pat. No.5,922,882 (Mori, et al.).

In addition to the usefulness of the benzotriazole phenols themselves,the benzotriazole phenols can also be used as synthons to formbenzotriazole phenolate salts that are also useful. For example in EPPatent Publication No. 351,732, the use of a variety of benzotriazolephenolate salts are used as the essential ingredient to give highcrystallization rates in polyester polymer compositions.

The need remains for substituted benzotriazole phenols for a variety ofuses and as synthons for benzotriazole phenolate salts.

SUMMARY

Disclosed herein are benzotriazole phenol compounds, protectedbenzotriazole phenol compounds, and methods for preparing benzotriazolephenol compounds and protected benzotriazole phenol compounds.

Among the embodiments disclosed herein are compositions comprising asubstituted or unsubstituted benzotriazole phenol with the structure ofFormula I:

wherein if R¹ comprises a hydrogen atom; R³ comprises an alkoxy oraryloxy group comprising 1-20 carbon atoms; and each R², R⁴, R⁵, R⁶, R⁷,and R⁸, independently comprises a hydrogen atom, an alkyl group, analkenyl group, an aryl group, or a halogen atom; or wherein if R¹comprises an —O—R⁹, a —N—R⁹R¹⁰, a —B(OR¹⁸)(OR¹⁹) group, or a —SiR²⁰ ₃group wherein R⁹ comprises a hydrogen atom, an alkyl group, an alkenylgroup, an aryl group, or a heteroatom-containing group comprising one ormore oxygen, nitrogen, sulfur, or phosphorous atoms, and R¹⁰ comprises ahydrogen atom, an alkyl group, an alkenyl group, an aryl group, or aheteroatom-containing group comprising one or more oxygen, nitrogen,sulfur, or phosphorous atoms, or R⁹ and R¹⁰ together with the atomsconnecting form a heterocyclic ring structure, each R¹⁸ and R¹⁹ isindependently a hydrogen atom, an alkyl group, an aryl group, or R¹⁸ andR¹⁹ together with the atoms connecting form a heterocyclic ringstructure, each R²⁰ group is an alkyl group; and each R², R³, R⁴, R⁵,R⁶, R⁷, and R⁸, independently comprises a hydrogen atom, an alkyl group,an alkenyl group, an aryl group, or a halogen atom.

In some embodiments, the compositions comprise the structure of FormulaII:

wherein X comprises an —O—, —NR¹⁰—, —S(O)—, —S(O)₂—, or —S— linkinggroup where R¹⁰ comprises a hydrogen atom, an alkyl group, or an arylgroup, each R², R³, R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, R¹⁶,and R¹⁷, independently comprises a hydrogen atom, an alkyl group, analkenyl group, an aryl group, or a halogen atom.

Also disclosed are protected substituted or unsubstituted benzotriazolephenols comprising the general structure Formula III or Formula IV:

wherein the group P is a protective group comprising an alkyl, asubstituted alkyl, or a silyl group;and wherein if R¹ comprises a hydrogen atom; R³ comprises an alkoxy oraryloxy group comprising 1-20 carbon atoms; and each R², R⁴, R⁵, R⁶, R⁷,and R⁸, independently comprises a hydrogen atom, an alkyl group, analkenyl group, an aryl group, or a halogen atom; orwherein if R¹ comprises an —O—R⁹, a —N—R⁹R¹⁰, a —B(OR¹⁸)(OR¹⁹) group, ora —SiR²⁰ ₃ group wherein R⁹ comprises a hydrogen atom, an alkyl group,an alkenyl group, an aryl group, or a heteroatom-containing groupcomprising one or more oxygen, nitrogen, sulfur, or phosphorous atoms,and R¹⁰ comprises a hydrogen atom, an alkyl group, an alkenyl group, anaryl group, or a heteroatom-containing group comprising one or moreoxygen, nitrogen, sulfur, or phosphorous atoms, or R⁹ and R¹⁰ togetherwith the atoms connecting form a heterocyclic ring structure, each R⁸and R¹⁹ is independently a hydrogen atom, an alkyl group, an aryl group,or R¹⁸ and R¹⁹ together with the atoms connecting form a heterocyclicring structure, each R²⁰ group is an alkyl group; and each R², R³, R⁴,R⁵, R⁶, R⁷, and R⁸, independently comprises a hydrogen atom, an alkylgroup, an alkenyl group, an aryl group, or a halogen atom; or

wherein the group P is a protective group comprising an alkyl, asubstituted alkyl, or a silyl group; and wherein X comprises an —O—,—NR¹⁰—, —S(O)—, —S(O)₂—, or —S— linking group where R¹⁰ comprises ahydrogen atom, an alkyl group, or an aryl group, each R², R³, R⁴, R⁵,R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, R¹⁶, and R¹⁷, independentlycomprises a hydrogen atom, an alkyl group, an alkenyl group, an arylgroup, or a halogen atom.

Also disclosed herein are methods of preparing substituted benzotriazolephenols comprising providing a protected phenolic compound of FormulaIII:

wherein the group P is a protective group comprising an alkyl, asubstituted alkyl, or a silyl group; R¹ comprises a leaving groupselected from a halogen atom, a triflate group, a tosylate group, or asulfonate group; and each R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸, independentlycomprises a hydrogen atom, an alkyl group, an alkenyl group, an arylgroup, or a halogen atom; providing a compound with the general formulaR²¹—Z—X—H wherein R²¹ comprises a hydrogen atom, an alkyl group, analkenyl group, an aryl group, or a halogen atom; Z comprises an alkyl oraryl group, or a single bond; X comprises an —O—, —NR¹⁰—, —S(O)—,—S(O)₂—, or —S— linking group where R¹⁰ comprises a hydrogen atom, analkyl group, or an aryl group; providing a palladium-based catalystcomprising at least one palladium-phosphine complex; providing at leastone base; providing at least one solvent; mixing the protected phenoliccompound of Formula III, the compound with the general formulaR²¹—Z—X—H, the palladium-based catalyst, the at least one base, and theat least one solvent to form a reaction mixture; and heating thereaction mixture to a temperature of at least 100° C. to effect acoupling reaction.

DETAILED DESCRIPTION

One class of useful phenolics are 2-(2-hydroxyphenyl)benzotriazoles orbenzotriazole phenols. Benzotriazole phenols are an important class ofUV absorbers, and in some cases, can absorb in the visible range aswell. These compounds are often used as additives in materials,particularly polymeric materials, and can be used as synthons to preparebenzotriazole phenolate salts, which can also be useful as additives inmaterials, especially polymeric materials.

Disclosed herein are substituted benzotriazole phenols which have arange of properties and can be used to prepare benzotriazole phenolatesalts. Additionally, protected substituted benzotriazole phenols, wherethe phenolic —OH group is protected, that is to say that it is an —OPgroup where P is the protective group, are also disclosed. Methods forpreparing substituted benzotriazole phenols using coupling reactions arealso disclosed.

The terms “a”, “an”, and “the” are used interchangeably with “at leastone” to mean one or more of the elements being described.

The term “alkyl” refers to a monovalent group that is a radical of analkane, which is a saturated hydrocarbon. The alkyl can be linear,branched, cyclic, or combinations thereof and typically has 1 to 20carbon atoms. In some embodiments, the alkyl group contains 1 to 18, 1to 12, 1 to 10, 1 to 8, 1 to 6, or 1 to 4 carbon atoms. Examples ofalkyl groups include, but are not limited to, methyl, ethyl, n-propyl,isopropyl, n-butyl, isobutyl, tert-butyl (t-butyl), n-pentyl, n-hexyl,cyclohexyl, n-heptyl, n-octyl, and ethylhexyl.

The term “alkenyl” refers to a monovalent group that is a radical of analkene, which is a hydrocarbon with at least one carbon-carbon doublebond. The alkenyl can be linear, branched, cyclic, or combinationsthereof and typically contains 2 to 20 carbon atoms. In someembodiments, the alkenyl contains 2 to 18, 2 to 12, 2 to 10, 4 to 10, 4to 8, 2 to 8, 2 to 6, or 2 to 4 carbon atoms. Exemplary alkenyl groupsinclude ethenyl, n-propenyl, and n-butenyl.

The term “heteroatom substituted” refers to an alkyl, aryl or othergroup which contains heteroatoms. These heteroatoms may be pendantatoms, for example, halogens or catenary atoms such as nitrogen, oxygen,boron, or sulfur.

The term “halogen” or “halogen atom” as used herein refers to fluorine,chlorine, bromine, or iodine.

The term “alkoxy” refers to a group with the general structure —O—R,where R is an alkyl group. The term “aryloxy” refers to a group with thegeneral structure —O—R, where R is an aryl group. In some instances, theterm alkoxy is used generically to describe both alkoxy and aryloxygroups.

The term “aryl” refers to an aromatic carbocyclic group that is aradical containing 1 to 5 rings which may be connected or fused. Thearyl group may be substituted with alkyl or heteroalkyl groups. Examplesof aryl groups include phenyl groups, naphthalene groups and anthracenegroups.

The terms “room temperature” and “ambient temperature” are usedinterchangeably to mean temperatures in the range of 20° C. to 25° C.

The term “protective group” as used herein refers to a P portion of thegeneral formula —OP, where O is an oxygen atom. The protective group isa reactive group which can be replaced with a hydrogen atom to form ahydroxyl group —OH, by a variety of techniques that are well understoodin the art. Examples of protective groups are described below and in theExamples section.

Unless otherwise indicated, all numbers expressing feature sizes,amounts, and physical properties used in the specification and claimsare to be understood as being modified in all instances by the term“about.” Accordingly, unless indicated to the contrary, the numbers setforth are approximations that can vary depending upon the desiredproperties using the teachings disclosed herein.

The substituted benzotriazole phenols of this disclosure have thegeneral structure shown in Formula I below:

In Formula I, at least one of R¹ and R³ comprises a substituent group,that is to say a group other than a hydrogen atom. In many embodiments,both R¹ and R³ comprise substituent groups. In some embodiments R¹ isnot substituted i.e. R¹ comprises a hydrogen atom, in many otherembodiments R¹ is a substituent group or another linked benzotriazolephenol group, as will described in greater detail below.

In embodiments where R¹ is not substituted (i.e. is a hydrogen atom), R³comprises an alkoxy or aryloxy group comprising 1-20 carbon atoms, andeach R², R⁴, R⁵, R⁶, R⁷, and R⁸, independently comprises a hydrogenatom, an alkyl group, an alkenyl group, an aryl group, or a halogenatom. In one embodiment, R¹ comprises a hydrogen atom, R³ comprises analkoxy group comprising 4 carbon atoms, and each R², R⁴, R⁵, R⁶, R⁷, andR⁸, independently comprises a hydrogen atom.

In a wide variety of embodiments R¹ comprises a substituent group. Inthese embodiments, R¹ comprises a halogen atom, or a group comprising an—O—R⁹, a —N—R⁹R¹⁰, a

—B(OR¹⁸)(OR¹⁹), or a —SiR²⁰ ₃. In these embodiments R⁹ comprises ahydrogen atom, an alkyl group, an alkenyl group, an aryl group, or aheteroatom-containing group comprising one or more oxygen, nitrogen,sulfur, or phosphorous atoms, and R¹⁰ comprises a hydrogen atom, analkyl group, an alkenyl group, an aryl group, or a heteroatom-containinggroup comprising one or more oxygen, nitrogen, sulfur, or phosphorousatoms, or R⁹ and R¹⁰ together with the atoms connecting form aheterocyclic ring structure, each R¹⁸ and R¹⁹ is independently ahydrogen atom, an alkyl group, an aryl group, or R¹⁸ and R¹⁹ togetherwith the atoms connecting form a heterocyclic ring structure, each R²⁰group is an alkyl group, and each R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸,independently comprises a hydrogen atom, an alkyl group, an alkenylgroup, an aryl group, or a halogen atom. Each of these embodiments willbe described in greater detail below.

In some embodiments, R¹ comprises a relatively small substituent group,one which is of smaller molecular weight and/or steric size relative tothe benzotriazole phenol base molecule. In other embodiments, the R¹group is a substituent group that is comparable in size and/or stericsize to the benzotriazole phenol base molecule, and is in fact anotherbenzotriazole phenol linked to the benzotriazole phenol base molecule byan oxygen, nitrogen-based, or sulfur-based linking group. Examples ofthe first type, where R¹ comprises a relatively small substituent group,will be presented first.

In some embodiments, R¹ comprises a halogen atom. Suitable halogen atomsinclude fluorine, bromine, chlorine and iodine. Bromine (Br) andchlorine (Cl) are particularly suitable.

In some embodiments, where R¹ comprises an —O—R⁹ group wherein R⁹comprises

an alkyl group with 1-20 carbon atoms, or an aryl group. In many ofthese embodiments, R³ is also a substituent group, typically R³ is analkyl group with 1-20 carbon atoms.

In some embodiments, R⁹ comprises an alkyl group with 1-6 carbon atoms,in one particular embodiment R⁹ comprises an alkyl group with 4 carbonatoms, and R³ is an alkyl group with 8 carbon atoms, typically aniso-octyl group.

In other embodiments, R⁹ comprises an aryl group comprising asubstituted phenyl group. In some particular embodiments, R⁹ comprises a3-methyl phenyl group or a 4-methyl phenyl group, and R³ is an alkylgroup with 8 carbon atoms, typically an iso-octyl group.

In another group of embodiments, R¹ comprises an —N—R⁹R¹⁰ group. In someof these embodiments, R⁹ comprises a hydrogen atom, an alkyl group with1-20 carbon atoms, or an aryl group. In these embodiments, R¹⁰independently comprises a hydrogen atom or alkyl group with 1-6 carbonatoms. In many of these embodiments, R³ is also a substituent group,typically R³ is an alkyl group with 1-20 carbon atoms.

In one embodiment, both R⁹ and R¹⁰ comprise a hydrogen atom. In otherembodiments, R⁹ comprises an alkyl group with 1-6 carbon atoms, or anaryl group comprising a 4-alkyl substituted phenyl group, wherein thealkyl substituted group has 1-6 carbon atoms, and R¹⁰ comprises ahydrogen atom.

In one particular embodiment, R⁹ comprises an alkyl group with 1 carbonatom (a methyl group), R¹⁰ comprises a hydrogen atom, and R³ is an alkylgroup with 8 carbon atoms, typically an iso-octyl group. In oneparticular embodiment, R⁹ comprises an alkyl group with 6 carbon atoms,R¹⁰ comprises a hydrogen atom, and R³ is an alkyl group with 8 carbonatoms, typically an iso-octyl group. In yet another particularembodiment, R⁹ comprises a 4-alkyl substituted phenyl group, wherein thealkyl substituent group has 6 carbon atoms (i.e. the group comprises a4-hexyl phenyl group), R¹⁰ comprises a hydrogen atom, and R³ is an alkylgroup with 8 carbon atoms, typically an iso-octyl group.

In another particular embodiment, R¹ comprises a —B(OH)₂ group, in otherembodiments R¹ comprises —B(—O—C(Me)₂-C(Me)₂-O—), and R³ is an alkylgroup with 8 carbon atoms, typically an iso-octyl group.

In another particular embodiment, R¹ comprises a —SiR²⁰ ₃ group whereR²⁰ comprises an alkyl group with 1-6 carbon atoms, in some embodimentsR²⁰ comprises 3 carbon atoms, typically R²⁰ comprises an isopropylgroup.

As mentioned above, in other embodiments the R¹ group is a substituentgroup that is comparable in size and/or steric size to the benzotriazolephenol base molecule, and is in fact another benzotriazole phenol linkedto the benzotriazole phenol base molecule by an oxygen, nitrogen-based,or sulfur-based linking group. Examples of this second type of compoundare described by Formula II below:

where the R¹ group is an —X—R⁹ group an X is a linking group comprisingan —O—, —NR¹⁰—, —S(O)—, or —S—, where S(O) is a sulfinyl group S═O, andwhere R¹⁰ comprises a hydrogen atom, an alkyl group, or an aryl group.The R⁹ group in these embodiments is another benzotriazole phenol group,which may be the same or different from the base benzotriazole phenolgroup. In these embodiments, each R², R³, R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹²,R¹³, R¹⁴, R¹⁵, R¹⁶, and R¹⁷, independently comprises a hydrogen atom, analkyl group, an alkenyl group, an aryl group, or a halogen atom.

In some embodiments of the compounds of Formula II, X comprises an—NR¹⁰— linking group where R¹⁰ comprises a hydrogen atom, or an alkylgroup comprising 1-3 carbon atoms. Typically in these embodiments, theR³ and R¹⁶ groups are substituent groups, where R³ and R¹⁶ each comprisean alkyl group with 1-20 carbon atoms. Typically, each R², R⁴, R⁵, R⁶,R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, and R¹⁷, is a hydrogen atom.

In one particular embodiment, X comprises an —NR¹⁰— linking group whereR¹⁰ comprises a hydrogen atom, the R³ and R¹⁶ groups are alkyl groupswith 8 carbon atoms, typically iso-octyl groups, and each R², R⁴, R⁵,R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, and R¹⁷, is a hydrogen atom.

In another particular embodiment, X comprises an —NR¹⁰— linking groupwhere R¹⁰ comprises an alkyl group with 1 carbon atom (a methyl group),the R³ and R¹⁶ groups are alkyl groups with 8 carbon atoms, typicallyiso-octyl groups, and each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴,R¹⁵, and R¹⁷, is a hydrogen atom.

In some embodiments of the compounds of Formula II, X comprises an —O—linking group. Typically in these embodiments, the R³ and R¹⁶ groups aresubstituent groups, where R³ and R¹⁶ each comprise an alkyl group with1-20 carbon atoms. Typically, each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹²,R¹³, R¹⁴, R¹⁵, and R¹⁷, is a hydrogen atom.

In one particular embodiment, X comprises an —O— linking group, the R³and R¹⁶ groups are alkyl groups with 8 carbon atoms, typically iso-octylgroups, and each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, andR¹⁷, is a hydrogen atom.

In some embodiments of the compounds of Formula II, X comprises a —S(O)—linking group. Typically in these embodiments, the R³ and R¹⁶ groups aresubstituent groups, where R³ and R¹⁶ each comprise an alkyl group with1-20 carbon atoms. Typically, each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹²,R¹³, R¹⁴, R¹⁵, and R¹⁷, is a hydrogen atom.

In one particular embodiment, X comprises a —S(O)— linking group, the R³and R¹⁶ groups are alkyl groups with 8 carbon atoms, typically iso-octylgroups, and each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, andR¹⁷, is a hydrogen atom.

In some embodiments of the compounds of Formula II, X comprises a —S—linking group. Typically in these embodiments, the R³ and R¹⁶ groups aresubstituent groups, where R³ and R¹⁶ each comprise an alkyl group with1-20 carbon atoms. Typically, each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹²,R¹³, R¹⁴, R¹⁵, and R¹⁷, is a hydrogen atom.

In one particular embodiment, X comprises a —S— linking group, the R³and R¹⁶ groups are alkyl groups with 8 carbon atoms, typically iso-octylgroups, and each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, andR¹⁷, is a hydrogen atom.

Also disclosed herein are a series of protected benzotriazole phenols.These compounds are ones in which the hydrogen atom of the phenolhydroxyl group (—OH) is replaced by a protective group (—OP). Typicallythese protective groups are alkyl, substituted alkyl, or silyl groups.Typically the protected benzotriazole phenols are isolated asintermediates in the preparation of the phenols. The protective groups(P) can be removed to generate the hydroxyl group and prepare thephenol.

The use of protective groups to protect the reactive phenol hydroxylgroup is well understood in the art. Protective groups can be used toprotect the phenol hydroxyl group during chemical synthesis so as toprevent side reactions with the reactive phenol hydroxyl group.Additionally, it can sometimes be desirable to isolate the protectedbenzotriazole phenol and convert it to the desired phenol prior to use.

Corresponding protected benzotriazole phenol compounds can be preparedand/or isolated for virtually all of the above described benzotriazolephenol compounds. These compounds can be described by the generalformulas Formula III and Formula IV below:

In Formula III, at least one of R¹ and R³ comprises a substituent group,that is to say a group other than a hydrogen atom. In many embodiments,both R¹ and R³ comprise substituent groups. In some embodiments R¹ isnot substituted i.e. R¹ comprises a hydrogen atom, in many otherembodiments R¹ is a substituent group or another linked benzotriazolephenol group, as will described in greater detail below.

In Formula III, the group P is a protective group. Typically theprotective group comprises an alkyl, a substituted alkyl, or a silylgroup. In some embodiments P comprises an alkyl group, typically amethyl group. In other embodiments, P comprises a substituted alkylgroup, such as an —CH₂OCH₃ group. In yet other embodiments, P comprisesa silyl group such as —Si((i-Pr)₃, where i-Pr is an iso-propyl group.

In embodiments where R¹ is not substituted (i.e. is a hydrogen atom), R³comprises an alkoxy or aryloxy group comprising 1-20 carbon atoms, andeach R², R⁴, R⁵, R⁶, R⁷, and R⁸, independently comprises a hydrogenatom, an alkyl group, an alkenyl group, an aryl group, or a halogenatom. In one embodiment, R¹ comprises a hydrogen atom, R³ comprises analkoxy group comprising 4 carbon atoms, and each R², R⁴, R⁵, R⁶, R⁷, andR⁸, independently comprises a hydrogen atom.

In a wide variety of embodiments R¹ comprises a substituent group. Inthese embodiments, R¹ comprises a halogen atom, or a group comprising an—O—R⁹, a —N—R⁹R¹⁰, a

—B(OR¹⁸)(OR¹⁹), or a —SiR²⁰ ₃. In these embodiments R⁹ comprises ahydrogen atom, an alkyl group, an alkenyl group, an aryl group, or aheteroatom-containing group comprising one or more oxygen, nitrogen,sulfur, or phosphorous atoms, and R¹⁰ comprises a hydrogen atom, analkyl group, an alkenyl group, an aryl group, or a heteroatom-containinggroup comprising one or more oxygen, nitrogen, sulfur, or phosphorousatoms, or R⁹ and R¹⁰ together with the atoms connecting form aheterocyclic ring structure, each R¹⁸ and R¹⁹ is independently ahydrogen atom, an alkyl group, an aryl group, or R¹⁸ and R¹⁹ togetherwith the atoms connecting form a heterocyclic ring structure, each R²⁰group is an alkyl group, and each R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸,independently comprises a hydrogen atom, an alkyl group, an alkenylgroup, an aryl group, or a halogen atom. Each of these embodiments willbe described in greater detail below.

In some embodiments, R¹ comprises a relatively small substituent group,one which is of smaller molecular weight and/or steric size relative tothe benzotriazole phenol base molecule. In other embodiments, the R¹group is a substituent group that is comparable in size and/or stericsize to the benzotriazole phenol base molecule, and is in fact anotherbenzotriazole phenol linked to the benzotriazole phenol base molecule byan oxygen or nitrogen-based linking group. Examples of the first type,where R¹ comprises a relatively small substituent group, will bepresented first.

In some embodiments, R¹ comprises a halogen atom. Suitable halogen atomsinclude fluorine, bromine, chlorine and iodine. Bromine (Br) andchlorine (Cl) are particularly suitable.

In some embodiments, where R¹ comprises an —O—R⁹ group wherein R⁹comprises

an alkyl group with 1-20 carbon atoms, or an aryl group. In many ofthese embodiments, R³ is also a substituent group, typically R³ is analkyl group with 1-20 carbon atoms.

In some embodiments, R⁹ comprises an alkyl group with 1-6 carbon atoms,in one particular embodiment R⁹ comprises an alkyl group with 4 carbonatoms, and R³ is an alkyl group with 8 carbon atoms, typically aniso-octyl group.

In other embodiments, R⁹ comprises an aryl group comprising asubstituted phenyl group. In some particular embodiments, R⁹ comprises a3-methyl phenyl group or a 4-methyl phenyl group, and R³ is an alkylgroup with 8 carbon atoms, typically an iso-octyl group.

In another group of embodiments, R¹ comprises an —N—R⁹R¹⁰ group. In someof these embodiments, R⁹ comprises an alkyl group with 1-20 carbonatoms, or an aryl group. In these embodiments, R¹⁰ independentlycomprises a hydrogen atom or alkyl group with 1-6 carbon atoms. In manyof these embodiments, R³ is also a substituent group, typically R³ is analkyl group with 1-20 carbon atoms.

In some embodiments, R⁹ comprises an alkyl group with 1-6 carbon atoms,or an aryl group comprising a 3-alkyl substituted phenyl group, whereinthe alkyl substituted group has 1-6 carbon atoms, and R¹⁰ comprises ahydrogen atom.

In one particular embodiment, R⁹ comprises an alkyl group with 1 carbonatom (a methyl group), R¹⁰ comprises a hydrogen atom, and R³ is an alkylgroup with 8 carbon atoms, typically an iso-octyl group. In oneparticular embodiment, R⁹ comprises an alkyl group with 6 carbon atoms,R¹⁰ comprises a hydrogen atom, and R³ is an alkyl group with 8 carbonatoms, typically an iso-octyl group. In yet another particularembodiment, R⁹ comprises a 4-alkyl substituted phenyl group, wherein thealkyl substituted group has 6 carbon atoms (i.e. the group comprises a4-hexyl phenyl group), R¹⁰ comprises a hydrogen atom, and R³ is an alkylgroup with 8 carbon atoms, typically an iso-octyl group.

In another particular embodiment, R¹ comprises a —B(OH)₂ group, in otherembodiments R¹ comprises —B(—O—C(Me)₂-C(Me)₂-O—), and R³ is an alkylgroup with 8 carbon atoms, typically an iso-octyl group.

In another particular embodiment, R¹ comprises a —SiR²⁰ ₃ group whereR²⁰ comprises an alkyl group with 1-6 carbon atoms, in some embodimentsR²⁰ comprises 3 carbon atoms, typically R²⁰ comprises an isopropylgroup.

As mentioned above, in other embodiments the R¹ group is a substituentgroup that is comparable in size and/or steric size to the benzotriazolephenol base molecule, and is in fact another benzotriazole phenol linkedto the benzotriazole phenol base molecule by an oxygen, nitrogen-based,or sulfur-based linking group. Examples of this second type of compoundare described by Formula II below:

where the R¹ group is an —X—R⁹ group an X is a linking group comprisingan —O—, —NR¹⁰—, —S(O)—, or —S—, where S(O) is a sulfinyl group S═O,S(O)₂ is a sulfonyl group O═S═O, and where R¹⁰ comprises a hydrogenatom, an alkyl group, or an aryl group. The R⁹ group in theseembodiments is another benzotriazole phenol group, which may be the sameor different from the base benzotriazole phenol group. In theseembodiments, each R², R³, R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵,R¹⁶, and R¹⁷, independently comprises a hydrogen atom, an alkyl group,an alkenyl group, an aryl group, or a halogen atom.

In Formula IV, the group P is a protective group. Typically theprotective group comprises an alkyl, a substituted alkyl, or a silylgroup. In some embodiments P comprises an alkyl group, typically amethyl group. In other embodiments, P comprises a substituted alkylgroup, such as an —CH₂OCH₃ group. In yet other embodiments, P comprisesa silyl group such as —Si((i-Pr)₃, where i-Pr is an iso-propyl group.

In some embodiments of the compounds of Formula IV, X comprises an—NR¹⁰— linking group where R¹⁰ comprises a hydrogen atom, or an alkylgroup comprising 1-3 carbon atoms. Typically in these embodiments, theR³ and R¹⁶ groups are substituent groups, where R³ and R¹⁶ each comprisean alkyl group with 1-20 carbon atoms. Typically, each R², R⁴, R⁵, R⁶,R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, and R¹⁷, is a hydrogen atom.

In one particular embodiment, X comprises an —NR¹⁰— linking group whereR¹⁰ comprises a hydrogen atom, the R³ and R¹⁶ groups are alkyl groupswith 8 carbon atoms, typically iso-octyl groups, and each R², R⁴, R⁵,R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, and R¹⁷, is a hydrogen atom.

In another particular embodiment, X comprises an —NR¹⁰— linking groupwhere R¹⁰ comprises an alkyl group with 1 carbon atom (a methyl group),the R³ and R¹⁶ groups are alkyl groups with 8 carbon atoms, typicallyiso-octyl groups, and each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴,R¹⁵, and R¹⁷, is a hydrogen atom.

In some embodiments of the compounds of Formula IV, X comprises an —O—linking group. Typically in these embodiments, the R³ and R¹⁶ groups aresubstituent groups, where R³ and R¹⁶ each comprise an alkyl group with1-20 carbon atoms. Typically, each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹²,R¹³, R¹⁴, R¹⁵, and R¹⁷, is a hydrogen atom.

In one particular embodiment, X comprises an —O— linking group, the R³and R¹⁶ groups are alkyl groups with 8 carbon atoms, typically iso-octylgroups, and each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, andR¹⁷, is a hydrogen atom.

In some embodiments of the compounds of Formula IV, X comprises a —S(O)—linking group. Typically in these embodiments, the R³ and R¹⁶ groups aresubstituent groups, where R³ and R¹⁶ each comprise an alkyl group with1-20 carbon atoms. Typically, each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹²,R¹³, R¹⁴, R¹⁵, and R¹⁷, is a hydrogen atom.

In one particular embodiment, X comprises a —S(O)— linking group, the R³and R¹⁶ groups are alkyl groups with 8 carbon atoms, typically iso-octylgroups, and each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, andR¹⁷, is a hydrogen atom.

In some embodiments of the compounds of Formula IV, X comprises a—S(O)₂— linking group. Typically in these embodiments, the R³ and R¹⁶groups are substituent groups, where R³ and R¹⁶ each comprise an alkylgroup with 1-20 carbon atoms. Typically, each R², R⁴, R⁵, R⁶, R⁷, R⁸,R¹¹, R¹², R¹³, R¹⁴, R¹⁵, and R¹⁷, is a hydrogen atom.

In one particular embodiment, X comprises a —S(O)₂— linking group, theR³ and R¹⁶ groups are alkyl groups with 8 carbon atoms, typicallyiso-octyl groups, and each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴,R¹⁵, and R¹⁷, is a hydrogen atom.

In some embodiments of the compounds of Formula IV, X comprises a —S—linking group. Typically in these embodiments, the R³ and R¹⁶ groups aresubstituent groups, where R³ and R¹⁶ each comprise an alkyl group with1-20 carbon atoms. Typically, each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹²,R¹³, R¹⁴, R¹⁵, and R¹⁷, is a hydrogen atom.

In one particular embodiment, X comprises a —S— linking group, the R³and R¹⁶ groups are alkyl groups with 8 carbon atoms, typically iso-octylgroups, and each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, andR¹⁷, is a hydrogen atom.

Also disclosed herein are methods for preparing substitutedbenzotriazole phenol compounds via coupling reactions. Cross-couplingreactions have been studied and used for many years. Carbon-carbon bondformation is the most studied form of cross-coupling, while non-carbonnucleophilic coupling partners were not discovered until the 1990's.Buchwald and Hartwig have made tremendous advances withcarbon-heteroatom coupling, however the scope can still be quitelimited, especially with hindered and/or deactivated substrates.Benzotriazole phenols are a particularly challenging substrate forcross-coupling due to the sterically hindered hydroxyl substituentlocated ortho to the halide and also due to the chelating effect of thebenzotriazole group, leading to deactivation of the metal catalyst.

Disclosed herein are the first examples of utilizing a cross-couplingmethod to install a heteroatom in the ortho position of a benzotriazole.In addition, no cross-coupling has been used to synthesize abis-benzotriazole phenol with a heteroatom linking group.

The method comprises preparing a reaction mixture that includes not onlythe reactants described in detail below, but also at least one solvent,at least one base, and at least one palladium-based catalyst. Thisreaction mixture is heated to a temperature of at least 100° C. toeffect the coupling reaction.

The methods for preparing substituted benzotriazole phenols compriseproviding a protected phenolic compound of Formula III:

where the group P is a protective group comprising an alkyl, asubstituted alkyl, or a silyl group; R¹ comprises a leaving groupselected from a halogen atom, a triflate group, a tosylate group, or asulfonate group; and each R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸, independentlycomprises a hydrogen atom, an alkyl group, an alkenyl group, an arylgroup, or a halogen atom; providing a compound with the general formulaR²¹—Z—X—H wherein R²¹ comprises a hydrogen atom, an alkyl group, analkenyl group, an aryl group, or a halogen atom; Z comprises an alkyl oraryl group, or a single bond; X comprises an —O—, —NR¹⁰—, —S(O)—, or —S—linking group where R¹⁰ comprises a hydrogen atom, an alkyl group, or anaryl group; providing a palladium-based catalyst comprising at least onepalladium-phosphine complex; providing at least one base; providing atleast one solvent; mixing the protected phenolic compound of FormulaIII, the compound with the general formula R²¹—Z—X—H, thepalladium-based catalyst, the at least one base, and the at least onesolvent; and permitting them to react in a coupling reaction. The Pgroup is then removed to replace the —OP group with an —OH group to formthe phenol functionality, resulting in the substituted benzotriazolephenols described above.

In some embodiments, the P group is an alkyl group of silyl group. Insome specific embodiments, the P group is a methyl group or a tri-alkylsilyl group.

Any suitable group can be used as the leaving group R¹. In someembodiments, the leaving group R¹ comprises a halogen atom. Bromineatoms are particularly suitable leaving groups, but other halogens,especially chlorine, may also be suitable.

Each R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸, independently comprises a hydrogenatom, an alkyl group, an alkenyl group, an aryl group, or a halogenatom. Typically at least one of these groups comprises a substituentgroup, meaning that it is an atom or group other than a hydrogen atom.In some embodiments, each R², R⁴, R⁵, R⁶, R⁷, and R⁸ group is a hydrogenatom, and the group R³ comprises a substituent group, typically an alkylgroup. In some specific embodiments, R³ comprises an alkyl group with 8carbon atoms, typically an iso-octyl group.

A wide variety of compounds with the general formula R²¹—Z—X—H can beused to couple with the compound of Formula III. In some embodiments,the compound with the general formula R²¹—Z—X—H is a relatively simplecompound, whereas in other embodiments, the compound with the generalformula R²¹—Z—X—H is similar in structure and complexity to the compoundof Formula III.

Examples of relatively simple compounds with the general formulaR²¹—Z—X—H are those where X is —O—, and the R²¹—Z— group comprises analkyl group, or a substituted aromatic group. In these embodiments, theR²¹—Z—X—H compounds are alcohols or phenols. Examples of such R²¹—Z—X—Hcompounds are H₃C—CH₂—CH₂—CH₂—OH (n-butanol) in which R²¹ is a hydrogenatom, Z is —H₂C—CH₂—CH₂—CH₂— group, and X is —O—. Other examples areones in which R²¹—Z— is a substituted aromatic ring, so that theR²¹—Z—X—H compound is a substituted phenol such as 3-methyl phenol or4-methyl phenol.

Other examples of relatively simple compounds with the general formulaR²¹—Z—X—H are those where X is —NR¹⁰—, where R¹⁰ comprises a hydrogenatom, an alkyl group, or an aryl group, and the R²¹—Z— group comprisesan alkyl group, or a substituted aromatic group. Examples of suchR²¹—Z—X—H compounds are H₃C—NH₂ (methyl amine) in which R²¹ is ahydrogen atom, Z is a —CH₂— group, and X is —NR¹⁰—, where R¹⁰ comprisesa hydrogen atom and H₃C—H₂C—CH₂—CH₂—CH₂—CH₂—NH₂ (hexyl amine) in whichR²¹ is a hydrogen atom, Z is a —H₂C—CH₂—CH₂—CH₂—CH₂— group, and X is—NR¹⁰—, where R¹⁰ comprises a hydrogen atom. Other examples are ones inwhich R²¹—Z— is a substituted aromatic ring, so that the R²¹—Z—X—Hcompound is a substituted aniline such as 4-hexyl aniline.

The methods of this disclosure also include embodiments where thecompound with the general formula R²¹—Z—X—H comprises a more complexstructure, being described by Formula IIIa:

where R¹ comprises the group —XH, where X comprises an —O—, —NR¹⁰—,—S(O)—, or —S— linking group where R¹⁰ comprises a hydrogen atom, analkyl group, or an aryl group; the group P is a protective groupcomprising an alkyl, a substituted alkyl, or a silyl group; and each R²,R³, R⁴, R⁵, R⁶, R⁷, and R⁸, independently comprises a hydrogen atom, analkyl group, an alkenyl group, an aryl group, or a halogen atom.

In some embodiments, the P group is an alkyl group of silyl group. Insome specific embodiments, the P group is a methyl group or a tri-alkylsilyl group.

Each R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸, independently comprises a hydrogenatom, an alkyl group, an alkenyl group, an aryl group, or a halogenatom. Typically at least one of these groups comprises a substituentgroup, meaning that it is an atom or group other than a hydrogen atom.In some embodiments, each R², R⁴, R⁵, R⁶, R⁷, and R⁸ group is a hydrogenatom, and the group R³ comprises a substituent group, typically an alkylgroup. In some specific embodiments, R³ comprises an alkyl group with 8carbon atoms, typically an iso-octyl group. In some specificembodiments, X comprises an —O—, —NR¹⁰—, —S(O)—, or —S— linking groupwhere R¹⁰ comprises a hydrogen atom or a methyl group.

In an alternative embodiment of the method of this disclosure, thecompound with the general formula R²¹—Z—XH comprises NH₃, and thecoupling reaction comprises a second coupling reaction to form acompound of Formula IV:

where the group P is a protective group comprising an alkyl, asubstituted alkyl, or a silyl group; and X comprises an —NR¹⁰— linkinggroup where R¹⁰ comprises a hydrogen atom, each R², R³, R⁴, R⁵, R⁶, R⁷,R⁸, R¹, R¹², R¹³, R¹⁴, R¹⁵, R¹⁶, and R¹⁷, independently comprises ahydrogen atom, an alkyl group, an alkenyl group, an aryl group, or ahalogen atom. In this coupling reaction, two compounds of Formula IIIare linked via a —NH— linking group.

Each R², R³, R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, R¹⁶, and R¹⁷,independently comprises a hydrogen atom, an alkyl group, an alkenylgroup, an aryl group, or a halogen atom. Typically at least two of thesegroups comprises a substituent group, meaning that it is an atom orgroup other than a hydrogen atom. In some embodiments, each R², R⁴, R⁵,R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, and R¹⁷ group is a hydrogen atom,and the groups R³ and R¹⁶ comprise substituent groups, typically alkylgroups. In some specific embodiments, R³ and R¹⁶ comprise alkyl groupswith 8 carbon atoms, typically iso-octyl groups.

As to the other components of the reaction mixture, the at least onesolvent, the at least one base and the at least one palladium-basedcatalyst, a wide variety of suitable materials are useful. Examples ofsuitable solvents include: hydrocarbon solvents such as hexane, heptane,toluene or benzene; ethers such as dioxane or THF (tetrahydrofuran);halogenated solvents such as dichloromethane or chloroform; and acetatessuch as ethylacetate; aqueous solvents including water or water and oneor more water miscible solvent such as an alcohol (such astert-butanol); and mixtures thereof. Examples of suitable bases includea wide array of inorganic or organic bases including: metal hydroxidesor alkoxides such as sodium hydroxide, potassium hydroxide, sodiumethoxide, or sodium tert-butoxide; metal carbonates and phosphates suchas potassium carbonate or cesium carbonate, or potassium phosphate;lithium salts such as n-butyl lithium, or lithium hexamethyldisilazane;sodium hydride; organic amine bases such as triethyl amine; and thelike. The palladium-based catalysts comprise palladium-phosphinecomplexes. The palladium-phosphine complexes are typically generated insitu by the combination of a palladium-based precatalyst and at leastone phosphine ligand. Examples of suitable palladium-based precatalystsand suitable phosphine ligands are described in greater detail in theExamples section. Particularly suitable palladium-based precatalystsinclude: palladium acetate; allyl palladium chloride; andtris(dibenzylideneacetone)dipalladium. Particularly suitable phosphineligands include:2-(Dicyclohexylphosphino)-2′,4′,6′-tri-i-propyl-1,1′-biphenyl (XPhos);2-(Di-t-butylphosphino)-3-methoxy-6-methyl-2′-4′-6′-tri-i-propyl-1,1′-biphenyl(RockPhos); and2-(Di-t-butylphosphino)-3,6-dimethoxy-2′,4′,6′-tri-i-propyl-1,1′-biphenyl(t-buBrettPhos) all available from Strem.

The compounds formed in the coupling reactions contain protectedphenolic groups (that is to say groups —OP). After the couplingreactions are carried out, the protecting groups P can be removed andreplaced by a hydrogen atom to form the phenol functionality accordingto well understood de-protection reactions to form the substitutedbenzotriazole phenol compounds of this disclosure.

Descriptions for the preparation of each of these substitutedbenzotriazole phenol compounds is described in detail in the Examplessection below.

EXAMPLES

These examples are merely for illustrative purposes only and are notmeant to be limiting on the scope of the appended claims. All parts,percentages, ratios, etc. in the examples and the rest of thespecification are by weight, unless noted otherwise. Solvents were AlfaAesar (ChemSeal grade) and were used with no further purification.Solvents that were used in separations, isolations, chromatography, andother general use were obtained from EMD (Omnisolv Grade).

The following abbreviations are used throughout the Examples: M=molar;min=minutes; h=hours; equiv=equivalents; x=times; g=grams;mg=milligrams; mmol=millimoles; L=liters; mL=milliliters; rt=roomtemperature; aq=aqueous;

Materials

The following is a table of commercially available materials andreagents that were used.

Compound Supplier Bases sodium ethoxide (ca. 20% in Ethanol) TCI Americasodium tert-butoxide TCI America n-butyllithium (1.6M in hexanes)Sigma-Aldrich potassium carbonate EMD Millipore cesium carbonate AlfaAesar potassium hydroxide EMD Millipore triethylamine Sigma-Aldrichsodium bicarbonate Sigma-Aldrich ammonium chloride VWR Oxidants1,3-Dibromo-5,5-dimethylhydantoin Alfa Aesar hydrogen peroxide, 30% J.T.Baker urea hydrogen peroxide adduct Alfa Aesar m-chloroperoxybenzoicacid Alfa Aesar Ligands 2-(Dicyclohexylphosphino)-2′,4′,6′-tri-i-propyl-Strem 1,1′-biphenyl (XPhos)2-(Di-t-butylphosphino)-3-methoxy-6-methyl-2′-4′- Strem6′-tri-i-propyl-1,1′-biphenyl (RockPhos)2-(Di-t-butylphosphino)-3,6-dimethoxy-2′,4′,6′- Stremtri-i-propyl-1,1′-biphenyl (t-buBrettPhos)1,1′bis(diphenylphospino)ferrocene Strem Catalyststris(dibenzylideneacetone)dipalladium Strem palladium acetate TCIAmerica allylpalladium(II) chloride dimer Lancaster copper acetate AlfaAesar Methanesulfonato(2-(di-t-butylphosphino)-3,6- Stremdimethoxy-2′,4′,6′-tri-i-propyl-1,1′-biphenyl)(2′-amino-1,1′-biphenyl-2-yl)palladium(II) (XPhos Precatalyst)Methanesulfonato(2-(di-t-butylphosphino)-3- Stremmethoxy-6-methyl-2′,4′,6′-tri-i-propyl-1,1′-biphenyl)(2′-amino-1,1′-biphenyl-2- yl)palladium(II) (RockPhosPrecatalyst) Methanesulfonato(2-(di-t-butylphosphino)-3,6- Stremdimethoxy-2′,4′,6′-tri-i-propyl-1,1′-biphenyl)(2′-amino-1,1′-biphenyl-2-yl)palladium(II) (t-BuBrettPhos Precatalyst)Reagents p-tolylboronic acid Aldrich Chemical trimethylborate Alfa Aesariodomethane Alfa Aesar triisopropylchlorosilane Alfa Aesar borontribromide Sigma-Aldrich thionyl chloride Alfa Aesartrifluoromethanesulfonic anhydride Oakwood2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3- TCI America tetramethylbutyl)phenolm-cresol Alfa Aesar n-butanol Sigma-Aldrich methylamine hydrochlorideAldrich Chemical 4-n-hexylaniline Alfa Aesar hexylamine Alfa Aesarammonia (0.5M in dioxane) Sigma Alrich scandium triflate Strem4-methylbenzenethiol toluene Alfa Aesar potassium thioacetate Alfa Aesar3,5-bis(trifluoromethyl)aniline Alfa Aesar1-bromo-4-(heptadecafluorooctyl)benzene Sigma Aldrich 1-iodooctadecaneAlfa Aesar

Structural Formulas of Compounds Disclosed

The table below presents a summary of the structural formulas for thecompounds disclosed in this application and prepared in the synthesespresented below. This table is added merely for clarity and is notexhaustive.

Structure Example MW Name

1 402.34 2-(2H-1,2,3- benzotriazol-2-yl)-6- bromo-4-(2,4,4-trimethylpentan-2- yl)phenol

1 416.36 2-(3-bromo-2- methoxy-5-(2,4,4- trimethylpentan-2-yl)phenyl)-2H-1,2,3- benzotriazole

2 2-(3-bromo-2- (methoxymethoxy)-5- (2,4,4-trimethylpentan-2-yl)phenyl)-2H-1,2,3- benzotriazole

3 2-(3-chloro-2- methoxy-5-(2,4,4- trimethylpentan-2-yl)phenyl)-2H-1,2,3- benzotriazole

4 353.47 3-(2H-1,2,3- benzotriazol-2-yl)-2- methoxy-5-(2,4,4-trimethylpentan-2- yl)phenol

5 409.57 2-(3-butoxy-2- methoxy-5-(2,4,4- trimethylpentan-2-yl)phenyl)-2H-1,2,3- benzotriazole

5 395.55 2-(2H-1,2,3- benzotriazol-2-yl)-6- butoxy-4-(2,4,4-trimethylpentan-2- yl)phenol

6 443.59 2-(2-methoxy-3-(m- tolyloxy)-5-(2,4,4- trimethylpentan-2-yl)phenyl)-2H-1,2,3- benzotriazole

6 429.56 2-(2H-1,2,3- benzotriazol-2-yl)-6- (m-tolyloxy)-4-(2,4,4-trimethylpentan-2- yl)phenol

7 443.59 2-(2-methoxy-3-(p- tolyloxy)-5-(2,4,4- trimethylpentan-2-yl)phenyl)-2H-1,2,3- benzotriazole

7 429.56 2-(2H-1,2,3- benzotriazole-2-yl)-6- (p-tolyloxy)-4-(2,4,4-trimethylpentan-2- yl)phenol

8 352.48 3-(2H- benzo[d][1,2,3]triazol- 2-yl)-2-methoxy-5-(2,4,4-trimethylpentan- 2-yl)aniline

8 338.46 2-amino-6-(2H- benzo[d][1,2,3]triazol- 2-yl)-4-(2,4,4-trimethylpentan-2- yl)phenol

9 366.51 3-(2H-1,2,3- benzotriazol-2-yl)-2- methoxy-N-methyl-5-(2,4,4-trimethylpentan- 2-yl)aniline

9 352.48 2-(2H-1,2,3- benzotriazole-2-yl)-6- (methylamino)-4-(2,4,4-trimethylpentan- 2-yl)phenol

10 351.47 3-(2H- benzo[d][1,2,3]triazol- 2-yl)-N-hexyl-2-methoxy-5-(2,4,4- trimethylpentan-2- yl)aniline

10 422.62 2-(2H- benzo[d][1,2,3]triazol- 2-yl)-6-(hexylamino)- 4-(2,4,4-trimethylpentan-2- yl)phenol

11 427.57 3-(2H- benzo[d][1,2,3]triazol- 2-yl)-N-(4- hexylphenyl)-2-methoxy-5-(2,4,4- trimethylpentan-2- yl)aniline

11 413.55 2-(2H- benzo[d][1,2,3]triazol- 2-yl)-6-((4-hexylphenyl)amino)-4- (2,4,4-trimethylpentan- 2-yl)phenol

12 558.68 2-(3-bromo-2- ((triisopropylsilyl)oxy)- 5-(2,4,4-trimethylpentan-2- yl)phenyl)-2H- benzo[d][1,2,3]triazole

12 495.78 2-(2H-1,2,3- benzotriazol-2-yl)-6- ((triisopropylsilyl)oxy)-4-(2,4,4- trimethylpentan-2- yl)phenol

13 381.28 (3-(2H-1,2,3- benzotriazol-2-yl)-2- methoxy-5-(2,4,4-trimethylpentan-2- yl)phenyl)boronic acid

14 687.93 bis(3-(2H-1,2,3- benzotriazol-2-yl)-2- methoxy-5-(2,4,4-trimethylpentan-2- yl)phenyl)amine

14 659.88 6,6′-azanediylbis(2-(2H- benzo[d][1,2,3]triazol-2-yl)-4-(2,4,4- trimethylpentan-2- yl)phenol)

15 701.96 N-(3-(2H- benzo[d][1,2,3]triazol- 2-yl)-2-methoxy-5-(2,4,4-trimethylpentan- 2-yl)phenyl)-3-(2H- benzo[d][1,2,3]triazol-2-yl)-2-methoxy-N- methyl-5-(2,4,4- trimethylpentan-2- yl)aniline

15 673.91 6,6′- (methylazanediyl)bis(2- (2H- benzo[d][1,2,3]triazol-2-yl)-4-(2,4,4- trimethylpentan-2- yl)phenol

16 485.52 3-(2H-1,2,3- benzotriazol-2-yl)-2- methoxy-5-(2,4,4-trimethylpentan-2- yl)phenyl trifluoromethanesulfonate

16 688.92 2,2′-(oxybis(2- methoxy-5-(2,4,4- trimethylpentan-2-yl)-3,1-phenylene))bis(2H- benzo[d][1,2,3]triazole)

16 660.86 6,6′-oxybis(2-(2H- benzo[d][1,2,3]triazol- 2-yl)-4-(2,4,4-trimethylpentan-2- yl)phenol

17 720.98 2,2′-(sulfinylbis(2- methoxy-5-(2,4,4- trimethylpentan-2-yl)-3,1-phenylene))bis(2H- benzo[d][1,2,3]triazole)

17 692.92 6,6′-sulfinylbis(2-(2H- benzo[d][1,2,3]triazol-2-yl)-4-(2,4,4- trimethylpentan-2- yl)phenol)

18 704.98 bis(3-(2H- benzo[d][1,2,3]triazol- 2-yl)-2-methoxy-5-(2,4,4-trimethylpentan- 2-yl)phenyl)sulfane

18 676.92 6,6′-thiobis(2-(2H- benzo[d][1,2,3]triazol- 2-yl)-4-(2,4,4-trimethylpentan-2- yl)phenol)

19 241.25 2-(2H- benzo[d][1,2,3]triazol- 2-yl)-4-methoxyphenol

20 564.58 3-(2H-benzotriazol-2- yl)-N-(3,5- bis(trifluoromethyl)phenyl)-2-methoxy-5- (2,4,4-trimethylpentan- 2-yl)aniline

20 550.55 2-(2H-benzotriazol-2- yl)-6-((3,5- bis(trifluoromethyl)phenyl)amino)-4-(2,4,4- trimethylpentan-2- yl)phenol

21 846.63 3-(2H-benzotriazol-2- yl)-2-methoxy-N-(4-(perfluorooctyl)phenyl)- 5-(2,4,4- trimethylpentan-2- yl)aniline

21 832.61 2-(2H-benzotriazol-2- yl)-6-((4- (perfluorooctyl)phenyl)amino)-4-(2,4,4- trimethylpentan-2- yl)phenol

22 459.65 2-(2-methoxy-3-(p- tolylthio)-5-(2,4,4- trimethylpentan-2-yl)phenyl)-2H- benzo[d][1,2,3]triazole

22 445.63 2-(2H-benzotriazol-2- yl)-6-(p-tolylthio)-4-(2,4,4-trimethylpentan- 2-yl)phenol

23 461.62 2-(2H-benzotriazol-2- yl)-6-(p-tolylsulfinyl)- 4-(2,4,4-trimethylpentan-2- yl)phenol

24 477.62 2-(2H-benzotriazol-2- yl)-6-tosyl-4-(2,4,4- trimethylpentan-2-yl)phenol

25 708.92 6,6′-sulfonylbis(2-(2H- benzotriazol-2-yl)-4-(2,4,4-trimethylpentan- 2-yl)phenol)

26 912.37 6,6′- (octadecylazanediyl) bis(2-(2H-benzotriazol-2-yl)-4-(2,4,4- trimethylpentan-2- yl)phenol)

In the examples below automated flash chromatography (AFC) was carriedout using an ISOLERA system available from Biotage, Inc,Charlottesville, Va., USA. For these purifications Biotage SNAP Ultrasilica columns were used with a hexane/ethyl acetate gradient mixture.

All intermediates and products were confirmed using ¹H and ¹³C NuclearMagnetic Resonance (NMR) on a 500 MHz Bruker instrument. In some casesHRMS was also obtained.

A General Reaction Scheme I is presented below which was followed toprepare the compounds of this disclosure. Specific details are providedfor each Example.

Part A: Cross-Coupling. Protected phenol A is subjected tocross-coupling conditions with either a palladium or copper catalyst.For specific reaction conditions, see each individual example.

Palladium Catalysis (Buchwald-Hartwig Cross-Coupling):

Buchwald, Hartwig, and coworkers have reported in the literature atransformation in which aryl halides can be converted to heteroatoms byuse of a palladium catalyst and a bulky phosphine ligand. The followingcommercially available ligands (developed by Buchwald) have been used tosynthesize benzotriazole phenolic analogs in which a heteroatom has beenintroduced in the ortho position (see compound B). These ligands canalso be purchased already complexed to the palladium catalyst and arereferred to as precatalysts.

Copper Catalysis (Chan-Evans-Lam Coupling):

Copper can also be used to effect cross-coupling reactions betweenarylboronic acids and phenols, anilines, or arylthiols. This isconsidered to be a modification of the Ullmann condensation, asdescribed in Kürti, L.; Czakó. Strategic Applications of Named Reactionsin Organic Synthesis, 1^(st) ed. Burlington: MA, 2005, pp. 464-465. Thereaction is stoichiometric in copper salts and is typically performedunder ambient conditions.

Part B: Deprotection of Methyl Ether. The methoxy ether benzotriazole(B, P=Me) was dissolved in dichloromethane (0.1 M) and cooled to −78° C.while stirring under N₂. Boron tribromide (1 equivalent per protectedphenol) was added dropwise and the reaction mixture allowed to slowlywarm to room temperature. When the reaction was complete (analysis byTLC), water was added dropwise and the mixture was stirred for 10 min.The organic layer was separated and the aqueous layer extracted with DCM(2×). The combined organic layers were washed with saturated aqueousNaHCO₃ and brine, dried (Na₂SO₄ or MgSO₄), filtered and concentrated.The residue was purified (SiO₂) to give products in 78-98% yield.

Example 1 Synthesis of2-(3-bromo-2-methoxy-5-(2,4,4-trimethylpentan-2-yl)phenyl)-2H-1,2,3-benzotriazole(1)

Part A: Bromination.2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol (100 g, 309mmol) was placed in a 1 L round bottom flask fitted with a stir bar anddissolved in chloroform (500 mL). To this was added1,3-dibromo-5,5-dimethylhydantoin (DBDMH) (45.95 g, 161 mmol) and themixture stirred rt overnight. After such time, the mixture was filteredand concentrated to give a dark red residue. The residue wasrecrystallized from dichloromethane/ethanol to obtain white crystals.Multiple recrystallizations of the mother liquor yielded 113 g of pureproduct (91% yield).

Part B: Methylation. The reaction product from Part A was placed in a 1L round bottom flask fitted with a stir bar and dissolved inacetonitrile (400 mL). Potassium carbonate (20.70 g, 150 mmol) was addedfollowed by iodomethane (3.3 mL, 52.5 mmol). The mixture stirred rtovernight. After such time, the reaction mixture was partiallyconcentrated, diluted with ethyl acetate and filtered over celite. Thesolution was concentrated, giving a thick beige oil, which eventuallysolidified over time to give 20.8 g (quantitative yield) of product.

Example 2 Synthesis of2-(3-bromo-2-(methoxymethoxy)-5-(2,4,4-trimethylpentan-2-yl)phenyl)-2H-1,2,3-benzotriazole

This procedure is similar to that described in Organic Synthesis, 2007,84, 102. A 1 dram vial is fitted with a magnetic stirbar and chargedwith dimethoxymethane (0.33 mL, 3.72 mmol), toluene (1 mL) and ZnBr₂(0.1 mg). Acetyl chloride (0.26 mL, 3.72 mmol) was added slowly,dropwise. After 2 h, the reaction mixture is cooled to 0° C. anddiisopropylethylamine (0.54 mL, 3.1 mmol) is added to the reactionmixture slowly. The phenol is then added (1 g, 2.48 mmol) and themixture stirred overnight. The solution is diluted with ethyl acetate (1mL) and a saturated aqueous NH₄Cl solution (1 mL) is added and themixture continued to stir for 10 min. The organic layer was separatedand washed with brine, dried, filtered and purified by flash columnchromatography to give a beige solid (0.99 g, 89% yield) afterevaporation.

Example 3 Synthesis of2-(3-chloro-2-methoxy-5-(2,4,4-trimethylpentan-2-yl)phenyl)-2H-1,2,3-benzotriazole

Part A: Chlorination.2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol (2 g, 6.18mmol) was placed in a 200 mL round bottom flask fitted with a stir barand dissolved in acetonitrile (65 mL). To this was addedN-chlorosuccinimide (NCS) (0.908 g, 6.802 mmol) and the mixture refluxedovernight. After such time, the mixture was cooled to rt and quenchedwith 10% aqueous Na₂S₂O₃ and extracted with EtOAc. The combined organiclayers were dried (Na₂SO₄), filtered, and concentrated to give a beigesolid in quantitative yield. No further purification was performed.

Part B: Methylation. The reaction product from Part A (1.5 g, 4.19 mmol)was placed in a 100 mL round bottom flask fitted with a stir bar anddissolved in acetonitrile (50 mL). Potassium carbonate (1.738 g, 12.57mmol) was added followed by iodomethane (0.27 mL, 4.40 mmol). Themixture stirred rt overnight. After such time, the reaction mixture waspartially concentrated, diluted with ethyl acetate and filtered overcelite, concentrated, and purified by AFC. A beige oil was isolated,which eventually solidified over time to give 0.96 g (62%) of product.

Example 43-(2H-1,2,3-benzotriazol-2-yl)-2-methoxy-5-(2,4,4-trimethylpentan-2-yl)phenol

Into a vial equipped with a stir bar was placed benzotriazole 1 preparedin Example 1 (5.10 g, 12.24 mmol), potassium hydroxide (2.06 g, 36.72mmol), t-BuBrettPhos ligand (30 mg, 0.06 mmol), and t-BuBrettPhos Pdprecatalyst (40.6 mg, 0.06 mmol). The vial was fitted with a septa capand evacuated and backfilled with N₂. 1,4-Dioxane (24 mL) and deionizedwater (4.4 mL) were added and the reaction mixture stirred overnight at100° C. After such time, the reaction was diluted with EtOAc andacidified with 10% aq HCl and stirred for an additional 10 min. Aftersuch time, the organic layer was separated and the aqueous layerextracted with EtOAc (2×). The combined organic layers were washed withsaturated aqueous NaHCO₃, brine, dried (Na₂SO₄), filtered andconcentrated to give a residue that was purified via flash columnchromatography. A beige glassy solid was isolated (3.57 g, 83% yield).

Example 52-(2H-1,2,3-benzotriazol-2-yl)-6-butoxy-4-(2,4,4-trimethylpentan-2-yl)phenol

Into three flame dried 40-dram vials, each equipped with a stir bar andactivated 4 Å mol sieves was placed benzotriazole 1 prepared in Example1, (4.179 g, 10.04 mmol), cesium carbonate (4.91 g, 15.06 mmol),allylpalladium chloride dimer (18.4 mg, 0.5 mol %), and RockPhos ligand(23.4 mg, 0.5 mol %). Each vial was fitted with a septa cap andevacuated and backfilled with N₂ (3×). Toluene (10 mL), followed byanhydrous n-butanol (1.8 mL, 20.08 mmol) was added to each vial. Thevials were placed on a ChemGlass reaction block and heated to 100° C.for 72 h. After such time, the reaction mixtures were combined, filteredover celite, and concentrated. The crude residue was purified via flashcolumn chromatography to give a pale yellow solid (9.80 g, 79% yield).Following Part B (General Reaction Scheme I), the free phenol wasisolated as a beige solid after purification by flash columnchromatography (8.50 g, 85% yield).

Example 62-(2H-1,2,3-benzotriazol-2-yl)-6-(m-tolyloxy)-4-(2,4,4-trimethylpentan-2-yl)phenol

Into two flame dried 40-dram vials, each equipped with a stir bar andactivated 4 Å mol sieves was placed benzotriazole 1 prepared in Example1, (4.16 g, 10 mmol), potassium phosphate (4.25 g, 20 mmol),palladium(II) acetate (45 mg, 2 mol %), and RockPhos ligand (93 mg, 2mol %). Each vial was fitted with a septa cap and evacuated andbackfilled with N₂ (3×). Toluene (10 mL), followed by m-cresol (1.3 mL,12 mmol) was added to each vial. The vials were placed on a ChemGlassreaction block and heated to 100° C. for 16 h. After such time, thereaction mixtures were combined, filtered over celite, and concentrated.The crude residue was purified via flash column chromatography to give abeige solid (7.07 g, 80% yield. Following Part B (General ReactionScheme I), the free phenol was isolated as a beige solid afterpurification by flash column chromatography (6.50 g, 98% yield).

Example 72-(2H-1,2,3-benzotriazol-2-yl)-6-(p-tolyloxy)-4-(2,4,4-trimethylpentan-2-yl)phenol

Into a vial equipped with a stir bar was placed the reaction productfrom Example 4 (61 mg, 0.1726 mmol), p-tolylboronic acid (23.5 mg,0.1726 mmol), copper(II) acetate (31.3 mg, 0.1726 mmol), triethylamine(0.072 mL, 0.5177 mmol), and dichloromethane (1.7 mL). The vial wasplaced under a gentle stream of air and stirred rt overnight. After suchtime, the mixture was diluted with dichloromethane, filtered overcelite, concentrated and purified to give a yellow foam (53.4 mg, 70%yield). Following Part B (General Reaction Scheme I), the free phenolwas isolated as a beige solid (48 mg, 99% yield).

Example 8

Part A. To an oven-dried Schlenk flask fitted with a stir bar was added4 Å molecular sieves, sodium tert-butoxide (23.37 mmol, 2.25 g),Pd₂(dba)₃ (0.33 mmol, 306 mg), XPhos (0.83 mmol, 398 mg) andbenzotriazole 1 prepared in Example 1, (16.69 mmol, 6.95 g). The flaskwas then evacuated and flushed with N₂ (3×) and ammonia in dioxane (0.5M, 100 mL) was added via cannula. The Schlenk flask was closed andheated to 130° C. for 16 h. After such time, the reaction mixture wasdiluted with EtOAc, filtered, and concentrated. The crude oil waspurified via flash column chromatography to give a beige solid which wascarried on to Part B (General Reaction Scheme I). Besides the dimerdescribed in Example 14 below, a second compound was also isolated,which was identified as the mono-aniline (0.79 g, 13% yield). Thiscompound was subjected to the standard deprotection conditions (Part B,General Reaction Scheme I), and the free phenol was isolated as a yellowsolid (0.67 g, 85% yield).

Example 92-(2H-1,2,3-benzotriazol-2-yl)-6-(methylamino)-4-(2,4,4-trimethylpentan-2-yl)phenol

Into a flame dried vial equipped with a stir bar was placedbenzotriazole 1 prepared in Example 1, (416 mg, 1 mmol),tris(dibenzylideneacetone)dipalladium(0) (20 mg, 0.01 mmol), XPhosligand (20 mg, 0.04 mmol), sodium tert-butoxide (288 mg, 3 mmol), andmethylamine hydrochloride (203 mg, 3 mmol). The vial was fitted with asepta cap and evacuated and backfilled with N₂. Dioxane (5 mL) was addedand the reaction was heated to 130° C. for 16 h. After such time, themixture was cooled to rt, diluted with EtOAc and filtered over celite.The residue was purified via AFC. A white solid was isolated (325 mg,89% yield). Following Part B (General Reaction Scheme I), gave the freephenol as a yellow solid (180 mg, 78% yield).

Example 102-(2H-benzo[d][1,2,3]triazol-2-yl)-6-(hexylamino)-4-(2,4,4-trimethylpentan-2-yl)phenol

Into three flame dried vials equipped with a stir bar was placedbenzotriazole 1 prepared in Example 1, (1.66 g, 4 mmol),tris(dibenzylideneacetone)dipalladium(0) (73.3 mg, 0.08 mmol), XPhosligand (95.3 mg, 0.2 mmol), sodium tert-butoxide (538 mg, 5.6 mmol), and1-hexylamine (0.74 mL, 5.6 mmol). The vial was fitted with a septa capand evacuated and backfilled with N₂. Dioxane (20 mL) was added and thereaction was heated to 130° C. for 16 h. After such time, the mixtureswere cooled to rt, combined, diluted with EtOAc and filtered overcelite. The residue was purified via AFC. A beige solid was isolated(3.88 g, 74% yield). Following Part B (General Reaction Scheme I), gavethe free phenol as a yellow solid (3.32, 88% yield).

Example 112-(2H-benzo[d][1,2,3]triazol-2-yl)-6-((4-hexylphenyl)amino)-4-(2,4,4-trimethylpentan-2-yl)phenol

Into three flame dried vials equipped with a stir bar was placedbenzotriazole 1 prepared in Example 1, (1.66 g, 4 mmol),tris(dibenzylideneacetone)dipalladium(0) (73.3 mg, 0.08 mmol), XPhosligand (95.3 mg, 0.2 mmol), sodium tert-butoxide (538 mg, 5.6 mmol), and4-hexylaniline (1 mL, 5.6 mmol). The vial was fitted with a septa capand evacuated and backfilled with N₂. Dioxane (20 mL) was added and thereaction was heated to 130° C. for 16 h. After such time, the mixtureswere cooled to rt, combined, diluted with EtOAc and filtered overcelite. The residue was purified via AFC. A beige solid was isolated(3.88 g, 74% yield). Following Part B (General Reaction Scheme I), gavethe free phenol as a yellow solid (4.67 g, 96% yield).

Example 122-(2H-1,2,3-benzotriazol-2-yl)-6-((triisopropylsilyl)oxy)-4-(2,4,4-trimethylpentan-2-yl)phenol

Part A. The reaction product from Example 1 was silylated withtriisopropylchlorosilane (TIPS-Cl) following standard procedures.

Part B. The reaction product from Part A (1.57 g, 2.81 mmol) was placedinto a round bottom flask containing a stir bar and charged with N₂. THF(20 mL) was added and the flask cooled to −78° C. n-Butyl lithium (1.8mL, 2.81 mmol) was added and the mixture was allowed to slowly warm tort and stir for 3 h. After such time, the reaction was quenched withsaturated ammonium chloride and the product extracted with EtOAc (3×).The combined organic layers were washed with brine, dried and filtered.The crude residue was purified by AFC to give a colorless solid (0.74 g,55% yield).

Example 13 Synthesis of(3-(2H-1,2,3-benzotriazol-2-yl)-2-methoxy-5-(2,4,4-trimethylpentan-2-yl)phenyl)boronicacid

Into a flame dried round bottom flask equipped with a stir bar wasplaced benzotriazole 1 prepared in Example 1, (1.936 mmol, 0.806 g) andcooled to −78° C. under N₂. n-Butyl lithium (1.6M, 1.33 mL) was addedslowly. After 10 min, trimethylborate (0.28 mL, 2.517 mmol) was addeddropwise. The mixture stirred for 1.5 h at −78° C., then 1 h at 0° C.After such time, the mixture was quenched with 10% aq HCl (1 mL) andcontinued to stir for 10 min before being diluted with ethyl acetate.The organic layer was separated and the aqueous layer extracted (2×).The combined organic layers were washed with brine, dried and filtered.The crude residue was purified via flash column chromatography, givingan ivory colored solid (0.451 g. 61% yield).

Example 146,6′-azanediylbis(2-(2H-benzo[d][1,2,3]triazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol)

Part A. To an oven-dried Schlenk flask fitted with a stir bar was added4 Å molecular sieves, sodium tert-butoxide (23.37 mmol, 2.25 g),Pd₂(dba)₃ (0.33 mmol, 306 mg), XPhos (0.83 mmol, 398 mg) andbenzotriazole 1 prepared in Example 1, (16.69 mmol, 6.95 g). The flaskwas then evacuated and flushed with N₂ (3×) and ammonia in dioxane (0.5M, 100 mL) was added via cannula. The Schlenk flask was closed andheated to 130° C. for 16 h. After such time, the reaction mixture wasdiluted with EtOAc, filtered, and concentrated. The crude oil waspurified via flash column chromatography to give a beige solid.

Part B. The product of Part A was dissolved in dichloromethane (150 mL)and cooled to −78° C. while stirring under N₂. Boron tribromide (17.10mmol, 1.6 mL) was added dropwise and the reaction mixture allowed toslowly warm to rt. When the reaction was complete (analysis by TLC),water was added dropwise and the mixture was stirred for 10 min. Theorganic layer was separated and the aqueous layer extracted with DCM(2×). The combined organic layers were washed with saturated aqueousNaHCO₃ and brine, dried (Na₂SO₄ or MgSO₄), filtered and concentrated.The residue was recrystallized from hot acetone to give a yellowcrystalline solid (3.38 g, 61% yield from 1).

Example 156,6′-(methylazanediyl)bis(2-(2H-benzo[d][1,2,3]triazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol)

Part A. The reaction product from Example 14, Part A (12.79 mmol, 8.8 g)was dissolved in dimethylformamide (120 mL) and to this, sodium hydride(14.07 mmol, 0.56 g) was added under a stream of N₂ at rt. The mixturewas stirred 10 min and then iodomethane (14.07 mmol, 0.88 mL) was addedand stirring continued for another 2 h. The reaction was quenched withsaturated aq ammonium chloride and extracted with EtOAc (3×). Thecombined organic layers were washed with water and then brine, driedwith Na₂SO₄, filtered and concentrated. No further purification wasperformed.

Part B. The product of Part B was dissolved in dichloromethane (150 mL)and cooled to −78° C. while stirring under N₂. Boron tribromide (17.10mmol, 1.6 mL) was added dropwise and the reaction mixture allowed toslowly warm to rt. When the reaction was complete (analysis by TLC),water was added dropwise and the mixture was stirred for 10 min. Theorganic layer was separated and the aqueous layer extracted with DCM(2×). The combined organic layers were washed with saturated aqueousNaHCO₃ and brine, dried (Na₂SO₄ or MgSO₄), filtered and concentrated.The residue was recrystallized from hot acetone to give a yellowcrystalline solid (6.74 g, 60% yield from 1).

Example 166,6′-oxybis(2-(2H-benzo[d][1,2,3]triazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol)

Part A. The reaction product from Example 4 was triflated using standardprocedures. To form the compound3-(2H-1,2,3-benzotriazol-2-yl)-2-methoxy-5-(2,4,4-trimethylpentan-2-yl)phenyltrifluoromethanesulfonate:

Part B. The reaction product (0.99 mmol, 482 mg) from Part A was thenplaced into a flame-dried vial along with the reaction product fromExample 4 (0.99 mmol, 351 mg), potassium phosphate (1.99 mmol, 421 mg)and molecular sieves. The vial was then evacuated and flushed with N₂(3×) and toluene (10 mL) was added. The reaction mixture was stirred for72 h at 130° C. After such time, the mixture was cooled, filtered, andpurified by flash column chromatography to obtain 5 as a white solid (73mg, 11% yield). Following the procedure from Example 14, Part B, theproduct was obtained as an amber-colored crystalline solid (0.052 g, 76%yield).

Example 176,6′-sulfinylbis(2-(2H-benzo[d][1,2,3]triazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol)

6,6′-Thiobis(2-(2H-benzotriazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol)from Example 18 was oxidized using a literature procedure (Org Lett,1999, 1, 189).6,6′-Thiobis(2-(2H-benzotriazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol)(7.39 mmol, 5.0 g) was dissolved in ethanol (5 mL) along with scandiumtriflate (0.74 mmol, 364 mg) and hydrogen peroxide.urea adduct (8.5mmol, 820 mg). The reaction stirred at 80° C. overnight and the whiteprecipitate was filtered and washed with water and ethanol. A 2:1mixture of the sulfoxide:sulfone was isolated (4.18 g, 81% yield).

An alternative procedure can also be used. Benzotriazole 1 prepared inExample 1, (12 mmol, 5.0 g) was dissolved in THF under N₂ and cooled to−78° C. n-Butyl lithium (1.6M, 7.9 mL) was added slowly and the reactionstirred for 30 min. After such time, thionyl chloride (5.88 mmol, 0.43mL) was added and the reaction allowed to slowly warm to rt. After 2 h,the reaction was quenched with saturated ammonium chloride and theproduct was extracted with ethyl acetate (3×). The combined organiclayers were washed with brine, dried (Na₂SO₄), and filtered. The crudeproduct was purified by flash column chromatography to give a whitesolid (1.2 g, 28% yield). Following the procedure from Example 14, PartB, the product was obtained as an amber-colored crystalline solid (0.73g, 63% yield).

Example 186,6′-thiobis(2-(2H-benzo[d][1,2,3]triazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol)

To a flame dried vial equipped with a stir bar was placed3-bromo-2-methoxy-5-(2,4,4-trimethylpentan-2-yl)phenyl)-2H-1,2,3-benzotriazole(0.416 g, 1 mmol), potassium thioacetate (0.057 g, 0.5 mmol),Tris(dibenzylideneacetone)dipalladium(0) (0.023 g, 0.025 mmol),1,1′-Bis(diphenylphosphino)ferrocene (0.028 g, 0.05 mmol) and potassiumphosphate (0.127 g, 0.6 mmol). The vial was then evacuated and flushedwith N₂ (3×) and toluene (0.5 mL) and acetone (0.25 mL) was added. Thereaction mixture was stirred for 72 h at 130° C. After such time, themixture was cooled, filtered, and purified by flash columnchromatography to obtain 5 as a white solid (0.240 g, 68% yield).Following the procedure from Example 10, Part B, the product wasobtained as a white solid (0.230 g, 99% yield).

A specialized reaction different from the above General Reaction SchemeI was used to prepare Phenol-19 as shown in Example 19 below.

Example 19

The diazo compound above as synthesized following standard diazotizationprocedure (WO008131921; Bioorg. Med. Chem. Lett. 2010, 20, 4193-4195),followed by reductive cyclization to give Phenol-19.

Example 202-(2H-benzotriazol-2-yl)-6-((3,5-bis(trifluoromethyl)phenyl)amino)-4-(2,4,4-trimethylpentan-2-yl)phenol

Into a 250 mL Schlenk flask equipped with a stir bar was placedbenzotriazole 1 prepared in Example 1, (20.0 g, 48.03 mmol),tris(dibenzylideneacetone)dipalladium(0) (1.04 g, 1.14 mmol), XPhosligand (1.35 g, 2.75 mmol), sodium tert-butoxide (7.63 g, 79.4 mmol),and 3,5-bis(trifluoromethyl)aniline (8 mL, 51.36 mmol). The Schlenkflask evacuated and backfilled with N₂. Dioxane (200 mL) was added andthe reaction was heated to 130° C. for 16 h. After such time, themixture was cooled to rt, diluted with EtOAc, filtered over celite andconcentrated. The residue was purified via AFC. A brown solid wasisolated (26.8 g, 98% yield). Following Part B (General Reaction SchemeI), gave the free phenol as a yellow solid (21.3 g, 82% yield).

Example 212-(2H-triazol-2-yl)-6-((4-(perfluorooctyl)phenyl)amino)-4-(2,4,4-trimethylpentan-2-yl)phenol

Into two flame dried 40-dram vials, each equipped with a stir bar wasplaced the product from Example 8, Part A (1.162 g, 3.30 mmol),1-bromo-4-(heptadecafluorooctyl)benzene (2.0 g, 3.30 mmol),tris(dibenzylideneacetone)dipalladium(0) (60.4 mg, 0.066 mmol), XPhosligand (80 mg, 0.163 mmol), and sodium tert-butoxide (444 mg, 4.62mmol). Each vial was fitted with a septa cap and evacuated andbackfilled with N₂. Dioxane (20 mL) was added to each vial and the vialswere placed on a ChemGlass reaction block and heated to 130° C. for 16h. After such time, the mixtures were cooled to rt, diluted with EtOAc,combined, and filtered over celite and concentrated. The residue waspurified via AFC. A brown solid was isolated (4.41 g, 79% yield).Following Part B (General Reaction Scheme I), gave the free phenol as ayellow solid (3.41 g, 79% yield).

Example 222-(2H-benzotriazol-2-yl)-6-(p-tolylthio)-4-(2,4,4-trimethylpentan-2-yl)phenolbenzotriazole

Into a flame dried vial equipped with a stir bar was placed2-(2H-benzo[1,2,3]triazol-2-yl)-6-bromo-4-(2,4-dimethylpentan-2-yl)phenol(2.88 g, 6.92 mmol), tris(dibenzylideneacetone)dipalladium(0) (0.317 g,0.346 mmol), 1,1′bis(diphenylphospino)ferrocene (0.383 g, 0.692 mmol),potassium phosphate (1.76 g, 8.30 mmol), and 4-methylbenzenethioltoluene (1.031 g, 8.30 mmol). The vial was fitted with a septa cap andevacuated and backfilled with N₂. Toluene (14 mL) was added and thereaction was heated to 110° C. for 16 h. After such time, the mixtureswere cooled to rt, combined, diluted with EtOAc and filtered overcelite. The residue was purified via AFC. A beige solid was isolated(3.09 g, 97% yield). Following Part B (General Reaction Scheme I), gavethe free phenol as an ivory-colored solid (2.70 g, 90% yield).

Example 232-(2H-benzotriazol-2-yl)-6-(p-tolylsulfinyl)-4-(2,4,4-trimethylpentan-2-yl)phenol

The following was adapted from a literature procedure (Org Lett. 2003,5, 235). Aryl sulfide from Example 22 (1.2 g, 2.69 mmol) was added to avial equipped with a stir bar. Ethanol (7 mL) and hydrogen peroxide(30%, 1.5 mL) were added and N₂ was bubbled through the mixture forseveral minutes. Scandium triflate (0.265 g, 0.539 mmol) was added andthe mixture allowed to stir rt overnight. After such time, the reactionwas quenched with H₂O (2 mL) and filtered. The filtrate was purified byAFC and a white solid was obtained (0.764 g, 61% yield). Another 0.167 gof recrystallized product from the mother liquor was obtained for atotal of 0.931 g (75% yield) of product.

Example 242-(2H-benzotriazol-2-yl)-6-tosyl-4-(2,4,4-trimethylpentan-2-yl)phenol

Aryl sulfide from Example 22 (1.5 g, 3.366 mmol) was dissolved indichloromethane (17 mL) in a vial equipped with a stir bar.m-Chloroperoxybenzoic acid, 50 wt % (2.56 g, 7.40 mmol) was added andthe reaction stirred until complete by TLC. The reaction was thenquenched with saturated aqueous NaHCO₃ and the organic layer separated,dried (Na₂SO₄), filtered, and concentrated. It was purified by washingwith EtOAc and filtering. A white solid was obtained (1.34 g, 83%yield).

Example 256,6′-sulfonylbis(2-(2H-benzotriazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol)

6,6′-Sulfonylbis(2-(2H-benzotriazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol)was synthesized in a similar fashion as Example 24. Aryl sulfide fromExample 18 (4.5 g, 6.6 mmol) was dissolved in dichloromethane (33 mL) ina flask equipped with a stir bar. m-Chloroperoxybenzoic acid, 50 wt %(7.40 mmol, 5.05 g) was added and the reaction stirred until complete byTLC. The reaction was then quenched with sat'd aqueous NaHCO₃ and theorganic layer separated, dried (Na₂SO₄), filtered, and concentrated. Itwas purified by washing with EtOAc and filtering. A white solid wasobtained (2.9 g, 62% yield).

Example 266,6′-(octadecylazanediyl)bis(2-(2H-benzotriazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol)

Part A. The reaction product from Example 14, Part A (4.0 g, 5.81 mmol)was dissolved in dimethylformamide (60 mL) and to this, sodium hydride(6.40 mmol, 256 mg) was added under a stream of N₂ at rt. The mixturewas stirred 10 min and then 1-iodooctadecane (6.40 mmol, 2.43 g) wasadded and stirring continued for another 2 h. The reaction was quenchedwith saturated aq ammonium chloride and extracted with EtOAc (3×). Thecombined organic layers were washed with water and then brine, driedwith Na₂SO₄, filtered and concentrated. No further purification wasperformed.

Part B. The product of Part A was dissolved in dichloromethane (40 mL)and cooled to temperature of −78° C. while stirring under N₂. Borontribromide (12.20 mmol, 1.2 mL) was added dropwise and the reactionmixture allowed to slowly warm to rt. When the reaction was complete(analysis by TLC), water was added dropwise and the mixture was stirredfor 10 min. The organic layer was separated and the aqueous layerextracted with DCM (2×). The combined organic layers were washed withsaturated aqueous NaHCO₃ and brine, dried (Na₂SO₄ or MgSO₄), filteredand concentrated to give a viscous oil (5.16 g, 97% yield).

What is claimed is:
 1. A composition comprising a substitutedbenzotriazole phenol with the structure of Formula I:

wherein if R¹ is an —O—R⁹, a —N—R⁹R¹⁰, a —B(OR¹⁸)(OR¹⁹) group, or a—SiR²⁰ ₃ group wherein R⁹ is selected from an alkyl group, or an arylgroup, and R¹⁰ is selected from a hydrogen atom, an alkyl group, analkenyl group, an aryl group, or a heteroatom-containing groupcomprising one or more oxygen, nitrogen, sulfur, or phosphorous atoms,or R⁹ and R¹⁰ together with the atoms connecting form a heterocyclicring structure, each R¹⁸ and R¹⁹ is independently a hydrogen atom, analkyl group, an aryl group, or R¹⁸ and R¹⁹ together with the atomsconnecting form a heterocyclic ring structure, each R²⁰ group is analkyl group; and each R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸, independently is ahydrogen atom, an alkyl group, an alkenyl group, an aryl group, or ahalogen atom; and R³ is an alkyl group with 8 carbon atoms.
 2. Thecomposition of claim 1, wherein R¹ comprises an —O—R⁹ group wherein R⁹an alkyl group with 1-20 carbon atoms; or an aryl group.
 3. Thecomposition of claim 2, wherein R⁹ is: an alkyl group with 1-6 carbonatoms; or an aryl group comprising a substituted phenyl group.
 4. Thecomposition of claim 1, wherein R¹ comprises a —N—R⁹R¹⁰ group: whereinR⁹ is selected from an alkyl group with 1-20 carbon atoms; or an arylgroup; R¹⁰ is selected from a hydrogen atom or an alkyl group with 1-6carbon atoms.
 5. The composition of claim 4, wherein R⁹ is selectedfrom: an alkyl group with 1-6 carbon atoms; or an aryl group comprisinga 3-alkyl substituted phenyl group, wherein the alkyl substituted grouphas 1-6 carbon atoms; R¹⁰ is a hydrogen atom.
 6. The composition ofclaim 1, wherein R¹ comprises a hydrogen atom; R³ is an alkoxy groupcomprising 4 carbon atoms; and each R², R⁴, R⁵, R⁶, R⁷, and R⁸,independently is a hydrogen atom.
 7. The composition of claim 2, whereinR¹ comprises an —O—R⁹ group wherein R⁹ is an alkyl group with 4 carbonatoms.
 8. The composition of claim 2, wherein R¹ comprises an —O—R⁹group wherein R⁹ comprises an aryl group comprising a 3-methyl phenylgroup, or a 4-methyl phenyl group.
 9. The composition of claim 4,wherein R¹ comprises an —N—R⁹R¹⁰ group wherein R⁹ is an alkyl group with1 carbon atom, or an alkyl group with 6 carbon atoms; R¹⁰ is a hydrogenatom.
 10. The composition of claim 4, wherein R¹ comprises an —N—R⁹R¹⁰group wherein R⁹ is an aryl group comprising an alkyl substituted phenylgroup, wherein the alkyl substituted group has 1-20 carbon atoms; R¹⁰ isa hydrogen atom.
 11. The composition of claim 10, wherein the alkylsubstituted phenyl group is a 4-hexyl phenyl group.
 12. The compositionof claim 1, comprising the structure of Formula II:

wherein X comprises an —O—, —NR¹⁰—, —S(O)—, —S(O)₂—, or —S— linkinggroup where R¹⁰ is selected from a hydrogen atom, an alkyl group, or anaryl group, each R², R³, R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵,R¹⁶, and R¹⁷, independently independently is a hydrogen atom, an alkylgroup, an alkenyl group, an aryl group, or a halogen atom; and R³ andR¹⁶ are each an alkyl group with 8 carbon atoms.
 13. The composition ofclaim 12, wherein X is an —NR¹⁰— linking group where R¹⁰ is selectedfrom a hydrogen atom, an alkyl group comprising 1-3 carbon atoms. R³ andR¹⁶, each comprises an alkyl group with 1-20 carbon.
 14. The compositionof claim 12, wherein X comprises an —O— linking group.
 15. Thecomposition of claim 12, wherein X comprises an —NR¹⁰— linking groupwhere R¹⁰ is a hydrogen atom; and each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹²,R¹³, R¹⁴, R¹⁵, and R¹⁷, independently is selected from a hydrogen atom,an alkyl group, an alkenyl group, an aryl group, or a halogen atom. 16.The composition of claim 12, wherein X comprises an —NR¹⁰— linking groupwhere R¹⁰ is a methyl group; and each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹²,R¹³, R¹⁴, R¹⁵, and R¹⁷, independently is selected from a hydrogen atom,an alkyl group, an alkenyl group, an aryl group, or a halogen atom. 17.The composition of claim 12, wherein X comprises an —O— linking group;and each R², R⁴, R⁵, R⁶, R⁷, R⁸, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, and R¹⁷,independently is selected from a hydrogen atom, an alkyl group, analkenyl group, an aryl group, or a halogen atom.